Dr. Ryan Gordon joins the Stem Pharm team as Sr. V.P. of Business Development

Dr. Ryan Gordon has joined the Stem Pharm team as Sr. V.P. of Business Development and Commercialization. Gordon brings to Stem Pharm over 20 years of business, R&D, and operational experience in developing and commercializing innovative biopharmaceutical technologies to revolutionize disease treatment and improve patient outcomes. He has been a valued leader at large companies (3M) and emerging startups (Rion, StemoniX, Rebiotix) where he made significant contributions to the pioneering development of regenerative exosome and microbiome therapeutics, 3D organoids for drug discovery, and novel drug delivery technologies. Notably, Dr. Gordon led business and market development at StemoniX, commercializing the first industrial-scale 3D human neural and cardiac organoids for drug discovery and preclinical development and launching the company’s contract services business. He has contributed to numerous patents and has co-authored research publications related to stem cell applications in drug discovery and preclinical development, microbiome therapeutics, and transdermal drug delivery. Dr. Gordon earned a Ph.D. and B.S. in chemical engineering from the University of Minnesota and the University of Wisconsin-Madison, respectively. He is a certified Lean Six Sigma Black Belt and completed a mini-MBA at the University of St. Thomas.